One of the most important debates among health economists in rich nations is whether advances in biotechnology will spare their health care systems from a financial crisis. We must consider that prevalence rates of chronic diseases declined during the twentieth century and that this rate of...

One of the most important debates among health economists in rich nations is whether advances in biotechnology will spare their health care systems from a financial crisis. We must consider that prevalence rates of chronic diseases declined during the twentieth century and that this rate of...

The Indian Health Sector is a highly fragmented with a state of art private hospital industry, an unregulated group of standalone practitioners, a partially defunct public sector and growing insurance sector. The out of pocket payments form the largest portion of health financing. Just like...